Journal Publications

No. Author Title Journal Name Year (Month/Day)
1543 Burke RM, Ramani S, Lynch J, Cooper LV, Cho H, Bandyopadhyay AS, Kirkwood CD, Steele AD, Kang G Geographic disparities impacting oral vaccine performance: Observations and future directions. Clin Exp Immunol 2025 (Jan)
1542 Tack B, Vita D, Mbuyamba J, Ntangu E, Vuvu H, Kahindo I, Ngina J, Luyindula A, Nama N, Mputu T, Im J, Jeon H, Marks F, Toelen J, Lunguya O, Jacobs J, Van Calster B Developing a clinical prediction model to modify empirical antibiotics for non-typhoidal Salmonella bloodstream infection in children under-five in the Democratic Republic of Congo. BMC Infect Dis 2025 (Jan)
1541 Lee JH, Shin Y, Shin K-S, Park JY, Kim MS, Park Y-S, Kim W, Song JY, Noh JY, Cheong HJ, Kang C-Y, Seo SH, Kim J-O, Kim DR, Hwang NS, Yang JS, Kim JH, Shim B-S, Song M Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults. mSphere 2025 (Jan/28)
1540 Fleck-Vidal C, Doubell A, Gerke C, Lamichhane U, Ogilvie L, Sudbrak R, Kim JH, Wartel TA, Plant L Vaccines and AMR: An analysis of the funding landscape for human bacterial vaccines in low-and middle-income countries. Vaccine 2025 (Mar/07)
1539 Khanam F, Islam MT, Ahmmed F, Rajib MNH, Hossen MI, Chowdhury F, Khan AI, Bhuiyan MTR, Haque S, Biswas PK, Bhuiyan AI, Khan ZH, Amin MA, Rahman A, Rizvi SMS, Shirin T, Islam MN, Tiffany A, Breakwell L, Qadri F, Clemens JD Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis. BMJ Glob Health 2025 (Feb)
1538 Demirtas ED, Barnard R, Lee J, Jit M A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella. NPJ Vaccines 2025 (Feb)
1537 Khanam F, Rickett NY, Ahmmed F, Islam MT, Mbae CK, Im J, Aziz AB, Ongadi B, Chowdhury F, Khan AI, Akter A, Firoj MG, Rahman SIA, Haile K, Park SE, Mwebia MB, Mwangi M, Ngugi B, Behute MG, Kering K, Agampodi S, Kanungo S, Liu X, Pollard AJ, Zaman K, Kim DR, Kariuki S, Qadri F, Clemens JD Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh. BMC Infect Dis 2025 (Jan)
1536 Kostyanev T, Al-Mir H, Prifti K, Rasmussen LB, Abegaz FA, Teixeira Dos Santos P, Kwon SY, Prathan R, Luang Tongkum T, Chanchaithong P, Santanirand P, Kamjumphol W, Mogeni OD, Guarnacci T, Poudyal N, Holm M, Paveenkittiporn W, Chuanchuen R, Hendriksen RS External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories. J Antimicrob Chemother 2025 (Feb)
1535 Haque Pial R, Rai GK, Shrestha R, Das SK, Chapagain RH, Chaudhary S, Tamrakar D, Kanodia P, Thapa P, Vemula S, Gupta BP, Hill A, Kimathi D, Baiden R, Kim HS, Excler JL, Wartel TA, Sahastrabuddhe S, Saluja T The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country. Hum Vaccin Immunother 2025
1534 Zida A, Guiguemde T, Sawadogo MP, Tchekounou C, Soulama I, Barry CS, Siribie M, Marks F, Sangare I, Bamba S Schistosomiasis in Burkina Faso: review on 60 years' research. Ann Parasitol 2024
1533 Muangnoicharoen S, Wiangcharoen R, Lawpoolsri S, Nanthapisal S, Jongkaewwattana A, Duangdee C, Kamolratanakul S, Luvira V, Thanthamnu N, Chantratita N, Thitithanyanont A, Anh Wartel T, Excler JL, Ryser MF, Leong C, Mak TK, Pitisuttithum P Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial. Vaccine 2024 (May)
1532 White RG, Menzies NA, Portnoy A, Clark RA, Toscano CM, Weller C, Tufet Bayona M, Silal SP, Karron RA, Lee JS, Excler JL, Lauer JA, Giersing B, Lambach P, Hutubessy R, Jit M The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations. Vaccines (Basel) 2024 (Apr)
1531 Excler, J.L., L.P. Dumm, J.H. Kim COVID-19 Vaccine development and distribution in S.R. Quah, ed., International Encyclopedia of Public Health, 3rd Edition, Elsevier 2025
1530 The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet 2023 (Jul/22)
1529 Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. Lancet Infect Dis 2024 (Feb)
No.1543 Author Burke RM, Ramani S, Lynch J, Cooper LV, Cho H, Bandyopadhyay AS, Kirkwood CD, Steele AD, Kang G
Title Geographic disparities impacting oral vaccine performance: Observations and future directions.
Journal Name Clin Exp Immunol
Month / Year 02/2025
No.1542 Author Tack B, Vita D, Mbuyamba J, Ntangu E, Vuvu H, Kahindo I, Ngina J, Luyindula A, Nama N, Mputu T, Im J, Jeon H, Marks F, Toelen J, Lunguya O, Jacobs J, Van Calster B
Title Developing a clinical prediction model to modify empirical antibiotics for non-typhoidal Salmonella bloodstream infection in children under-five in the Democratic Republic of Congo.
Journal Name BMC Infect Dis
Month / Year 02/2025
No.1541 Author Lee JH, Shin Y, Shin K-S, Park JY, Kim MS, Park Y-S, Kim W, Song JY, Noh JY, Cheong HJ, Kang C-Y, Seo SH, Kim J-O, Kim DR, Hwang NS, Yang JS, Kim JH, Shim B-S, Song M
Title Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults.
Journal Name mSphere
Month / Year 02/2025
No.1540 Author Fleck-Vidal C, Doubell A, Gerke C, Lamichhane U, Ogilvie L, Sudbrak R, Kim JH, Wartel TA, Plant L
Title Vaccines and AMR: An analysis of the funding landscape for human bacterial vaccines in low-and middle-income countries.
Journal Name Vaccine
Month / Year 02/2025
No.1539 Author Khanam F, Islam MT, Ahmmed F, Rajib MNH, Hossen MI, Chowdhury F, Khan AI, Bhuiyan MTR, Haque S, Biswas PK, Bhuiyan AI, Khan ZH, Amin MA, Rahman A, Rizvi SMS, Shirin T, Islam MN, Tiffany A, Breakwell L, Qadri F, Clemens JD
Title Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis.
Journal Name BMJ Glob Health
Month / Year 02/2025
No.1538 Author Demirtas ED, Barnard R, Lee J, Jit M
Title A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella.
Journal Name NPJ Vaccines
Month / Year 02/2025
No.1537 Author Khanam F, Rickett NY, Ahmmed F, Islam MT, Mbae CK, Im J, Aziz AB, Ongadi B, Chowdhury F, Khan AI, Akter A, Firoj MG, Rahman SIA, Haile K, Park SE, Mwebia MB, Mwangi M, Ngugi B, Behute MG, Kering K, Agampodi S, Kanungo S, Liu X, Pollard AJ, Zaman K, Kim DR, Kariuki S, Qadri F, Clemens JD
Title Evaluation of naturally occurring IgG anti-Vi antibody titers as predictors and correlates of typhoid fever in Dhaka, Bangladesh.
Journal Name BMC Infect Dis
Month / Year 02/2025
No.1536 Author Kostyanev T, Al-Mir H, Prifti K, Rasmussen LB, Abegaz FA, Teixeira Dos Santos P, Kwon SY, Prathan R, Luang Tongkum T, Chanchaithong P, Santanirand P, Kamjumphol W, Mogeni OD, Guarnacci T, Poudyal N, Holm M, Paveenkittiporn W, Chuanchuen R, Hendriksen RS
Title External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.
Journal Name J Antimicrob Chemother
Month / Year 02/2025
No.1535 Author Haque Pial R, Rai GK, Shrestha R, Das SK, Chapagain RH, Chaudhary S, Tamrakar D, Kanodia P, Thapa P, Vemula S, Gupta BP, Hill A, Kimathi D, Baiden R, Kim HS, Excler JL, Wartel TA, Sahastrabuddhe S, Saluja T
Title The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country.
Journal Name Hum Vaccin Immunother
Month / Year 02/2025
No.1534 Author Zida A, Guiguemde T, Sawadogo MP, Tchekounou C, Soulama I, Barry CS, Siribie M, Marks F, Sangare I, Bamba S
Title Schistosomiasis in Burkina Faso: review on 60 years' research.
Journal Name Ann Parasitol
Month / Year 02/2025
No.1533 Author Muangnoicharoen S, Wiangcharoen R, Lawpoolsri S, Nanthapisal S, Jongkaewwattana A, Duangdee C, Kamolratanakul S, Luvira V, Thanthamnu N, Chantratita N, Thitithanyanont A, Anh Wartel T, Excler JL, Ryser MF, Leong C, Mak TK, Pitisuttithum P
Title Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial.
Journal Name Vaccine
Month / Year 06/2024
No.1532 Author White RG, Menzies NA, Portnoy A, Clark RA, Toscano CM, Weller C, Tufet Bayona M, Silal SP, Karron RA, Lee JS, Excler JL, Lauer JA, Giersing B, Lambach P, Hutubessy R, Jit M
Title The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.
Journal Name Vaccines (Basel)
Month / Year 06/2024
No.1531 Author Excler, J.L., L.P. Dumm, J.H. Kim
Title COVID-19 Vaccine development and distribution
Journal Name in S.R. Quah, ed., International Encyclopedia of Public Health, 3rd Edition, Elsevier
Month / Year 06/2024
No.1530 Author
Title The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
Journal Name Lancet
Month / Year 02/2024
No.1529 Author Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K
Title Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.
Journal Name Lancet Infect Dis
Month / Year 02/2024